Linda Fan, MD, on telehealth in the second stage of COVID-19

A recent study found that unopposed estrogen therapy reduces young-onset breast cancer risk, while combined estrogen-progestin therapy increases it.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

Eliminating a modest out-of-pocket cost significantly increased digital breast tomosynthesis use and reduced disparities across racial, ethnic, and language groups.

On this episode of Pap Talk, Emily Adhikari, MD answers frequently asked questions about the COVID-19 vaccine.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals rising breast cancer rates among minority women aged 65 to 74 years, highlighting the need for targeted screening and intervention strategies.